Compare $DMAC vs $TECX | Chartloom

Compare

$DMAC vs $TECX

DiaMedica Therapeutics Inc · Tectonic Therapeutic Inc

DMAC

DiaMedica Therapeutics Inc

TECX

Tectonic Therapeutic Inc

Compare $DMAC vs $TECX

Comparing DiaMedica Therapeutics Inc and Tectonic Therapeutic Inc

DMACDiaMedica Therapeutics Inc

TECXTectonic Therapeutic Inc

DMACDiaMedica Therapeutics Inc

Market cap

$449M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.0%

52W performance

19.7%

FCF yield

-7.0%

TECXTectonic Therapeutic Inc

Market cap

$440M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

11.6%

52W performance

51.9%

FCF yield

-16.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DMAC

TECX

Detailed metrics comparison

DMAC

DiaMedica Therapeutics Inc

TECX

Tectonic Therapeutic Inc

Market Cap

DMAC$449M

TECX$440M

Enterprise Value

DMAC$444M

TECX$213M

Price

DMAC$8.33

TECX$23.33

P/E Ratio

DMACN/A

TECXN/A

P/S Ratio

DMAC0.00x

TECX0.00x

EV/Sales

DMAC0.00x

TECX0.00x

EV/EBITDA

DMAC0.00x

TECX0.00x

P/B Ratio

DMAC11.58x

TECX1.97x

P/FCF Ratio

DMACN/A

TECXN/A

EV/FCF

DMAC-14.07x

TECX-2.95x

PEG Ratio

DMACN/A

TECXN/A

Forward P/E (NTM)

DMACN/A

TECXN/A

Forward P/S (NTM)

DMACN/A

TECXN/A

Revenue (TTM)

DMAC$0

TECX$0

Revenue Growth (YoY)

DMACN/A

TECXN/A

Forward Rev Growth

DMAC306.4%

TECX0.0%

Gross Margin (TTM)

DMAC0.0%

TECX0.0%

Operating Margin (TTM)

DMAC0.0%

TECX0.0%

EBITDA Margin (TTM)

DMAC0.0%

TECX0.0%

Net Margin (TTM)

DMAC0.0%

TECX0.0%

FCF Margin (TTM)

DMACN/A

TECXN/A

Net Income (TTM)

DMAC$-38M

TECX$-86M

FCF (TTM)

DMAC$-32M

TECX$-72M

EPS (TTM)

DMAC-$0.70

TECX-$4.52

ROE (TTM)

DMAC-7768.0%

TECX-3526.0%

ROA (TTM)

DMAC-6936.0%

TECX-3359.0%

ROIC (TTM)

DMAC-7766.0%

TECX-3521.0%

Cash

DMAC$5M

TECX$227M

Debt

DMAC$9K

TECX$186K

Net Cash/Debt

DMAC$5M

TECX$227M

Current Ratio (TTM)

DMAC6.72x

TECX22.29x

Quick Ratio (TTM)

DMAC6.63x

TECX21.90x

Debt/Equity (TTM)

DMAC0.00x

TECX0.00x

Debt/Assets (TTM)

DMAC0.0%

TECX0.0%

Interest Coverage (TTM)

DMACN/A

TECXN/A

Net Debt/EBITDA (TTM)

DMAC0.00x

TECX0.00x

Beta

DMAC0.96

TECX1.29

52W Performance

DMAC19.7%

TECX51.9%

YTD Performance

DMAC5.0%

TECX11.6%

% from 52W High

DMAC-20.1%

TECX-41.0%

% from 52W Low

DMAC58.8%

TECX52.3%

Asset Turnover (TTM)

DMAC0.00x

TECX0.00x

FCF Yield (TTM)

DMAC-7.0%

TECX-16.4%

Earnings Yield (TTM)

DMAC-8.4%

TECX-19.5%

Dividend Yield (TTM)

DMACN/A

TECXN/A

Rule of 40

DMAC0.0

TECX0.0

EV/GP/RG

DMACN/A

TECXN/A

Ticker research

View DMAC research View TECX research

Metric	DMAC DiaMedica Therapeutics Inc	TECX Tectonic Therapeutic Inc
Market & Valuation
Market Cap	$449M	$440M
Enterprise Value	$444M	$213M
Price	$8.33	$23.33
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	11.58x	1.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.07x	-2.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	306.4%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-86M
FCF (TTM)	$-32M	$-72M
EPS (TTM)	-$0.70	-$4.52
ROE (TTM)	-7768.0%	-3526.0%
ROA (TTM)	-6936.0%	-3359.0%
ROIC (TTM)	-7766.0%	-3521.0%
Financial Health
Cash	$5M	$227M
Debt	$9K	$186K
Net Cash/Debt	$5M	$227M
Current Ratio (TTM)	6.72x	22.29x
Quick Ratio (TTM)	6.63x	21.90x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.96	1.29
52W Performance	19.7%	51.9%
YTD Performance	5.0%	11.6%
% from 52W High	-20.1%	-41.0%
% from 52W Low	58.8%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-7.0%	-16.4%
Earnings Yield (TTM)	-8.4%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DMAC research	View TECX research

Valuation

P/S Ratio

DMAC

0.00x

TECX

0.00x

EV/FCF

DMAC

-14.07x

TECX

-2.95x

Growth & revenue

Forward Revenue Growth

DMAC

306.4%

TECX

0.0%

Profitability & performance

Gross Margin

DMAC

0.0%

TECX

0.0%

ROE

TECX

-3526.0%

DMAC

-7768.0%

FCF Yield %

DMAC

-7.0%

TECX

-16.4%

52-Week Performance

TECX

51.9%

DMAC

19.7%

Detailed metrics comparison

DMAC

DiaMedica Therapeutics Inc

TECX

Tectonic Therapeutic Inc

Market Cap

DMAC$449M

TECX$440M

Enterprise Value

DMAC$444M

TECX$213M

Price

DMAC$8.33

TECX$23.33

P/E Ratio

DMACN/A

TECXN/A

P/S Ratio

DMAC0.00x

TECX0.00x

EV/Sales

DMAC0.00x

TECX0.00x

EV/EBITDA

DMAC0.00x

TECX0.00x

P/B Ratio

DMAC11.58x

TECX1.97x

P/FCF Ratio

DMACN/A

TECXN/A

EV/FCF

DMAC-14.07x

TECX-2.95x

PEG Ratio

DMACN/A

TECXN/A

Forward P/E (NTM)

DMACN/A

TECXN/A

Forward P/S (NTM)

DMACN/A

TECXN/A

Revenue (TTM)

DMAC$0

TECX$0

Revenue Growth (YoY)

DMACN/A

TECXN/A

Forward Rev Growth

DMAC306.4%

TECX0.0%

Gross Margin (TTM)

DMAC0.0%

TECX0.0%

Operating Margin (TTM)

DMAC0.0%

TECX0.0%

EBITDA Margin (TTM)

DMAC0.0%

TECX0.0%

Net Margin (TTM)

DMAC0.0%

TECX0.0%

FCF Margin (TTM)

DMACN/A

TECXN/A

Net Income (TTM)

DMAC$-38M

TECX$-86M

FCF (TTM)

DMAC$-32M

TECX$-72M

EPS (TTM)

DMAC-$0.70

TECX-$4.52

ROE (TTM)

DMAC-7768.0%

TECX-3526.0%

ROA (TTM)

DMAC-6936.0%

TECX-3359.0%

ROIC (TTM)

DMAC-7766.0%

TECX-3521.0%

Cash

DMAC$5M

TECX$227M

Debt

DMAC$9K

TECX$186K

Net Cash/Debt

DMAC$5M

TECX$227M

Current Ratio (TTM)

DMAC6.72x

TECX22.29x

Quick Ratio (TTM)

DMAC6.63x

TECX21.90x

Debt/Equity (TTM)

DMAC0.00x

TECX0.00x

Debt/Assets (TTM)

DMAC0.0%

TECX0.0%

Interest Coverage (TTM)

DMACN/A

TECXN/A

Net Debt/EBITDA (TTM)

DMAC0.00x

TECX0.00x

Beta

DMAC0.96

TECX1.29

52W Performance

DMAC19.7%

TECX51.9%

YTD Performance

DMAC5.0%

TECX11.6%

% from 52W High

DMAC-20.1%

TECX-41.0%

% from 52W Low

DMAC58.8%

TECX52.3%

Asset Turnover (TTM)

DMAC0.00x

TECX0.00x

FCF Yield (TTM)

DMAC-7.0%

TECX-16.4%

Earnings Yield (TTM)

DMAC-8.4%

TECX-19.5%

Dividend Yield (TTM)

DMACN/A

TECXN/A

Rule of 40

DMAC0.0

TECX0.0

EV/GP/RG

DMACN/A

TECXN/A

Ticker research

View DMAC research View TECX research

Metric	DMAC DiaMedica Therapeutics Inc	TECX Tectonic Therapeutic Inc
Market & Valuation
Market Cap	$449M	$440M
Enterprise Value	$444M	$213M
Price	$8.33	$23.33
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	11.58x	1.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.07x	-2.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	306.4%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-86M
FCF (TTM)	$-32M	$-72M
EPS (TTM)	-$0.70	-$4.52
ROE (TTM)	-7768.0%	-3526.0%
ROA (TTM)	-6936.0%	-3359.0%
ROIC (TTM)	-7766.0%	-3521.0%
Financial Health
Cash	$5M	$227M
Debt	$9K	$186K
Net Cash/Debt	$5M	$227M
Current Ratio (TTM)	6.72x	22.29x
Quick Ratio (TTM)	6.63x	21.90x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.96	1.29
52W Performance	19.7%	51.9%
YTD Performance	5.0%	11.6%
% from 52W High	-20.1%	-41.0%
% from 52W Low	58.8%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-7.0%	-16.4%
Earnings Yield (TTM)	-8.4%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DMAC research	View TECX research